Buy Piclib Palbociclib 125 mg from India
Piclib contains palbociclib 125 mg in hard gelatin capsules. The pack shown is a 21-capsule oncology product manufactured by Hetero Healthcare. Palbociclib is a CDK4/6 inhibitor used only under oncologist supervision, mainly in treatment plans for HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy when this approach is prescribed by a specialist.
This U-HIV page is intended to help patients and caregivers check the trade name, active ingredient, strength, pack size and order terms before contacting a manager. The price is 42 USD per pack, the minimum order is 3 packs, and delivery from India is 30 USD. These commercial details do not replace medical assessment: palbociclib requires blood-count monitoring and a strict treatment calendar.
What Piclib is used for
Palbociclib slows cell-cycle progression by inhibiting cyclin-dependent kinases 4 and 6. In oncology, this mechanism is used together with endocrine therapy to help control hormone receptor-positive breast cancer where tumor growth is influenced by estrogen signaling. The exact combination, duration and dose modifications depend on the oncologist, previous therapy and laboratory results.
- Active substance: palbociclib 125 mg.
- Pack size: 21 capsules, usually matching a 21-days-on treatment phase.
- Prescription oncology medicine, not suitable for self-treatment.
- Used only with medical monitoring, including complete blood counts.
How treatment is usually organized
The well-known palbociclib capsule regimen starts at 125 mg once daily with food for 21 consecutive days followed by 7 days off, creating a 28-day cycle. This does not mean every patient should use the same plan. Dose reduction, interruption or discontinuation may be required if neutropenia, infection, liver issues, severe fatigue or other clinically relevant reactions occur.
Patients should discuss drug interactions before starting treatment. Strong CYP3A inhibitors or inducers, grapefruit products and some supportive medicines may affect palbociclib exposure. The oncologist also checks pregnancy status and contraception, because palbociclib can harm an unborn child.
Warnings and monitoring
Important safety concerns include neutropenia, infections, fatigue, nausea, stomatitis, diarrhea, hair thinning and changes in laboratory values. Interstitial lung disease or pneumonitis has also been reported with CDK4/6 inhibitors. Fever, chills, shortness of breath, chest discomfort, persistent cough, unusual bruising or severe weakness require urgent medical contact.
- Do not start Piclib without a written oncology prescription.
- Do not change the cycle or dose on your own.
- Keep capsules away from children and store as directed on the package.
- Show the package and all current medicines to your doctor before use.
Ordering from India
Piclib Palbociclib 125 mg can be requested through U-HIV with delivery from India. Before ordering, verify that the medicine, dose and pack size match the oncologist’s recommendation. The page is informational and does not provide diagnosis or treatment advice.